Drug war between generics and brand names?The state and its players find themselves at the heart of a battle between generic companies and innovator drug makers. And the two pharmaceutical lobbies are using numbers to duke it out. Effects of isotope shortage assessed Canada clobbered for quality of care BCMA preps for big negotiations with province Key longtime negotiator leaving after current round of talks Quebec slashes generic prices Canadians pay too much for generics: report Paper suggests paying pharmacists to provide additional services to moderate impact of price reductions and benefit the healthcare system The provinces' Pac-Man Quality stats key to medical education plan Explosion in number of students learning at satellite campuses changing ‘med school’ experience Should government intervene in drug markets? Not much point, says Fraser Institute Prescription dominance First Previous 90 91 92 93 94 Next Last
